GB1005821A - New antibiotic compositions - Google Patents
New antibiotic compositionsInfo
- Publication number
- GB1005821A GB1005821A GB30058/62A GB3005862A GB1005821A GB 1005821 A GB1005821 A GB 1005821A GB 30058/62 A GB30058/62 A GB 30058/62A GB 3005862 A GB3005862 A GB 3005862A GB 1005821 A GB1005821 A GB 1005821A
- Authority
- GB
- United Kingdom
- Prior art keywords
- spiramycin
- adipate
- adipic acid
- mixture
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
An aqueous solution of spiramycin adipate is prepared by adding water to a solid mixture of spiramycin and adipic acid particles and agitating the mass at ambient temperature.ALSO:A solid mixture for therapeutic use after dissolution in water comprises spiramycin and adipic acid, the particle size of the solids in the mixture being such that on addition of the mixture to water and agitation at ambient temperature an aqueous solution of spiramycin adipate is obtained within one minute. Equimolecular proportions of spiramycin and adipic acid may be used. The particle size may be such that all the particles pass through a 40 to 80-mesh B.S.S. sieve. The amount of water added may be such as to give up to a 30% (w/v) solution of spiramycin adipate. For mycoplasmosis in turkeys, a 10%-20% (w/v) solution of spiramycin adipate may be administered within 72 hours of formation.
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL296206D NL296206A (en) | 1962-08-03 | ||
| GB30058/62A GB1005821A (en) | 1962-08-03 | 1962-08-03 | New antibiotic compositions |
| FR1583151D FR1583151A (en) | 1962-08-03 | 1963-08-02 | |
| NL296206A NL140729B (en) | 1962-08-03 | 1963-08-02 | PROCEDURE FOR PREPARING SPIRAMYCIN ADIPATE SOLUTION DELIVERING POWDERS. |
| ES0290574A ES290574A1 (en) | 1962-08-03 | 1963-08-03 | Procedure for the preparation of new compositions of antimicrobial action (Machine-translation by Google Translate, not legally binding) |
| BE650716D BE650716A (en) | 1962-08-03 | 1964-07-17 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA623369 | 1962-08-03 | ||
| GB30058/62A GB1005821A (en) | 1962-08-03 | 1962-08-03 | New antibiotic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1005821A true GB1005821A (en) | 1965-09-29 |
Family
ID=26260246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB30058/62A Expired GB1005821A (en) | 1962-08-03 | 1962-08-03 | New antibiotic compositions |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE650716A (en) |
| GB (1) | GB1005821A (en) |
| NL (1) | NL296206A (en) |
-
0
- NL NL296206D patent/NL296206A/xx unknown
-
1962
- 1962-08-03 GB GB30058/62A patent/GB1005821A/en not_active Expired
-
1964
- 1964-07-17 BE BE650716D patent/BE650716A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL296206A (en) | |
| BE650716A (en) | 1964-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3065420D1 (en) | Pharmaceutical composition containing sanguinaria and galangal suitable for treatment of periodentitis and tumours | |
| ES395835A1 (en) | Cosmetic compositions and their use | |
| ES370058A1 (en) | Antibiotic compositions | |
| ES404748A1 (en) | Process for preparing injectionable compositions | |
| GB901107A (en) | Therapeutic composition and method of preparing same | |
| ES399906A1 (en) | Process for the production of dyestuff preparations | |
| JPS53127819A (en) | Stabilization of l-asocorbic acid and its salt | |
| GB1005821A (en) | New antibiotic compositions | |
| US2556688A (en) | Pharmaceutical methionine composition | |
| JPS5037949B1 (en) | ||
| JPS53102353A (en) | Granular stabilizing agent and its preparation | |
| GB1334271A (en) | Diazabicycloundecapentene derivative | |
| GB1354263A (en) | Therapeutic composition | |
| JPS5452718A (en) | Preparation of solid pharmaceuticals | |
| ES485157A1 (en) | Benzimidazolyl-2-carbamic acid esters, medicaments based thereon and process for their preparation. | |
| GB761227A (en) | Artificial lumber products and their manufacture | |
| JPS5170769A (en) | 10*111 jihidoro 33 karubokishishipuroheputajin oyobi sono nn okisaido | |
| ES405567A1 (en) | Composition for the treatment of asthma | |
| GB789565A (en) | An improved method for preventing table salt from caking due to moisture | |
| GB695916A (en) | A method for the manufacture of therapeutically effective agents from peloids | |
| ES318873A1 (en) | The method of preparing an adequate dry mix to be used as a substitute for portland cement (Machine-translation by Google Translate, not legally binding) | |
| ES421584A1 (en) | Radiological contrast media | |
| JPS5278819A (en) | Isolation of glutaric acid from composition containing glutaric acid, succinic acid and adipic acid | |
| GB833744A (en) | Treatment of boiler feed water | |
| GB794417A (en) | Improvements in octahydronaphthalene derivatives, compositions of matter containing said derivatives and their process of preparation |